Innophos holdings, inc. (IPHS)
CashFlow / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows provided by operating activities
Net income

6,451

1,401

8,694

4,820

14,090

6,246

10,915

-11,283

11,582

11,223

10,923

9,382

13,643

12,104

12,842

-4,633

5,433

13,603

11,943

11,328

18,320

20,628

14,185

14,596

10,940

11,567

12,403

13,392

16,706

16,504

27,588

20,950

18,857

20,746

25,969

19,262

-2,080

17,623

10,350

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

11,130

10,887

9,759

11,614

10,864

11,089

11,364

11,395

9,878

9,550

9,581

8,872

10,043

9,282

9,282

8,854

9,048

10,762

9,871

8,818

9,244

8,924

8,475

7,667

8,943

9,465

9,386

10,216

10,563

11,316

10,239

11,233

11,526

10,723

10,194

11,537

13,020

12,259

12,655

Amortization of deferred financing charges

107

108

107

108

107

107

108

107

107

108

107

175

168

169

168

170

160

142

143

133

130

131

132

134

137

141

147

456

141

142

145

147

149

154

158

168

5,568

983

431

Deferred income tax provision

34

139

69

2,622

6,909

97

0

-

-

-

-

-

-

-

-

-36,806

34

28

107

2,917

0

-71

0

874

-721

-460

1,791

1,712

-1,186

-25

-334

-999

2,242

1,593

2,543

1,978

-9,557

696

203

Gain on sale of building

-

-

-

-

-

-

-

0

0

0

153

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred profit sharing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-681

961

-311

-255

-365

-1,285

-209

-205

Share-based compensation

1,621

2,780

787

1,044

1,151

1,994

998

827

711

1,568

717

493

1,028

1,292

9

4,375

658

1,402

183

592

713

817

1,158

408

15

1,033

718

-1,407

991

1,107

1,221

1,128

1,094

1,755

2,273

1,166

2,008

1,195

721

Changes in assets and liabilities:
Decrease in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-1,749

Accounts receivable

7,262

-12,763

9,156

-528

-5,838

2,269

5,841

-2,004

5,227

1,049

6,748

-2,165

-5,195

-6,868

12,170

-20,875

-785

946

9,930

-4,162

-13,058

667

18,640

-11,110

-2,315

-8,196

15,708

-1,740

-4,956

-28,664

22,342

17,284

3,196

-4,120

11,794

2,234

-6,350

7,465

14,997

Inventories

-2,165

-1,108

-6,640

11,424

9,958

4,364

8,772

-2,876

-1,223

-10,878

9,228

-10,920

-16,612

-10,408

-6,072

2,986

-5,484

-1,305

-8,268

20,732

-478

-788

-16,412

23,356

4,270

13,983

-23,261

5,296

-412

2,680

-19,776

10,274

10,045

33,593

-8,891

-2,950

10,938

483

1,075

Other current assets

-1,876

13,944

-1,026

-10,195

4,881

4,789

-308

-1,275

-6,126

1,781

4,194

2,736

3,845

-13,066

7,119

-12,023

2,728

-16,688

2,719

-9,012

9,405

-6,153

-6,001

-9,595

-6,760

-2,063

-8,388

18,413

5,722

17,987

-20,571

6,265

-1,344

-5,178

-2,981

6,722

21,540

7,771

-1,763

Accounts payable

6,069

-3,551

-20,578

10,638

1,525

-1,777

-915

4,069

-1,177

-416

-5,973

17,248

-4,873

-3,982

6,310

-5,827

-6,465

12,471

-16,615

9,627

5,488

-1,558

638

-4,831

3,334

-6,228

9,973

-916

-5,162

10,742

-2,736

-5,496

-6,458

7,050

-1,035

9,498

5,469

-1,360

3,109

Other current liabilities

815

9,768

-5,542

-13,702

11,009

5,138

-5,856

-7,417

4,354

1,139

-3,827

-2,781

2,182

-1,441

-16,886

22,590

6,931

-1,160

-429

-6,801

4,471

-1,250

3,793

4,602

-945

-4,223

-11,058

-2,051

6,109

-4,262

-20,780

-19,416

13,141

-2,279

-6,131

5,447

36,924

3,462

-21,311

Other long-term assets and liabilities, net

8,521

1,807

1,280

-555

10,847

3,387

837

-13,054

248

1,199

1,884

-4,396

388

3,016

1,582

-4,354

-1,345

1,136

-1,271

2,346

453

-606

-1,372

3,152

-3,793

-602

3,745

-309

396

0

3,488

2,131

6

632

2,473

309

2,930

-370

120

Net cash provided by operating activities

7,882

26,255

-9,474

38,248

25,807

8,085

1,472

27,332

27,301

30,035

-10,679

57,305

39,765

45,113

-3,074

22,989

20,685

53,159

2,093

16,710

42,044

34,501

33,526

17,647

30,301

8,173

35,556

-258

27,412

43,521

29,860

-29,088

29,609

14,504

31,321

42,376

21,009

19,300

-6,727

Cash flows used for investing activities:
Capital expenditures

9,739

5,913

9,924

8,945

21,325

11,410

15,065

10,209

8,573

7,524

8,553

10,924

7,137

10,514

8,024

9,929

7,624

8,235

5,911

6,955

6,278

8,589

6,133

3,082

14,454

8,442

7,437

17,063

5,506

5,291

5,200

6,948

10,549

9,391

7,307

9,062

37,438

-8,059

-7,249

Proceeds from sale of building

-

-

-

-

-

-

-

0

0

0

1,028

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used for investing activities

-9,739

-5,913

-9,924

13,830

-21,325

-11,410

-15,065

-36,224

-133,557

-7,524

-7,525

-10,924

-7,137

-10,514

-8,024

-9,929

-7,624

-8,235

-5,911

-8,104

-6,572

-8,589

-6,133

-7,507

-14,454

-8,442

-7,437

-61,676

-32,599

-5,291

-5,200

-27,481

-10,549

-9,391

-7,307

-9,062

-6,822

-8,059

-7,249

Cash flows provided by financing activities:
Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

8

0

0

9

56

0

1

189

1

0

60

99

1,150

425

75

0

-

-

-

-

0

0

164

320

43

20

15

158

Long-term debt borrowings

14,000

2,000

35,000

0

25,000

21,000

40,000

58,000

132,000

0

14,000

5,000

0

13,000

23,000

3,000

46,000

40,000

70,000

9,000

0

0

0

35,007

0

25,000

3,000

318,000

10,000

0

5,000

22,000

0

0

0

-

-

-

-

Long-term debt repayments

4,000

2,000

5,000

45,000

10,000

36,000

5,000

43,000

17,000

9,000

10,000

20,000

30,000

14,001

5,001

76,001

4,000

1,001

1,001

1,001

11,002

16,000

8,001

34,000

6,000

11,000

25,000

259,000

26,000

23,000

1,000

11,000

1,000

1,000

6,000

21,000

190,000

56,000

0

Excess tax benefits from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

337

-15

0

-331

204

7

491

273

257

660

46

108

972

836

73

968

1,250

371

271

2,039

24

0

232

2,255

95

12

31

502

Common stock repurchases

-

-

-

-

-

-

-

-

-

-

-

-

-

318

0

-402

39,154

51,932

34,316

15,300

8,003

6,192

189

7,118

0

0

70

-1

7,255

0

0

0

6,139

0

17

0

0

0

0

Restricted stock forfeitures

0

23

212

365

0

0

251

457

0

378

360

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid

9,452

9,452

9,414

9,414

9,415

9,402

9,380

9,373

9,373

9,373

9,349

9,326

9,327

9,308

9,256

9,236

9,261

9,863

10,198

10,372

10,476

8,780

8,766

8,817

7,694

7,685

7,641

7,629

5,891

5,885

5,405

5,404

5,442

5,426

3,649

3,645

3,641

3,640

3,633

Net cash provided by financing activities

548

-9,475

20,374

-54,779

5,585

-24,402

25,369

5,375

105,627

-18,751

-5,709

-25,511

-39,355

-10,627

8,421

-81,976

-6,685

-22,304

24,947

-17,606

-28,821

-30,866

-16,749

-12,806

-12,433

6,463

-28,743

51,308

-28,408

-28,600

634

5,620

-12,581

-6,030

-7,091

-24,521

-26,423

-59,594

-2,973

Effect of foreign exchange rate changes on cash and cash equivalents

0

0

0

-181

740

-723

164

-433

-135

-64

226

-179

311

-194

206

774

-323

128

-90

43

45

81

-58

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash

-1,309

10,867

976

-2,882

10,807

-28,450

11,940

-3,950

-764

3,696

-23,687

20,691

-6,416

23,778

-2,471

-68,142

6,053

22,748

21,039

-8,957

6,696

-4,873

10,586

-3,044

3,414

6,194

-624

-9,756

-33,595

9,630

25,294

-50,949

6,479

-917

16,923

8,793

-12,236

-48,353

-16,949

Non-cash investing and financing activities:
Accrued additions to plant assets

418

280

4,544

4,327

-7,048

8,218

3,903

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-